BSE filing, NSE: ENTERO. Summary written from the filing by ALFA Finder's alert engine.
Entero Healthcare Solutions Ltd: key numbers
- Share price
- ₹1,900.40
- Market cap
- ₹8,279 Cr
- Revenue (annual)
- ₹6,591 Cr
- Net profit (annual)
- ₹115.0 Cr
- P/E (TTM)
- 59.4×Sector 53.9×
- Promoter holding
- 52.40%+0.00% QoQ
- FII holding
- 5.76%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Entero Healthcare Solutions Ltd
All →Entero Healthcare Solutions Legal & Regulatory
Entero's subsidiary Vasavi Medicare faces an INR 11.87 crore customer default. Vasavi has fully provided for the dues and plans legal recovery action.
- Value
- ₹11.87 Cr
Entero Healthcare Solutions Investor Presentation: Key Takeaways
Q2FY27 revenue Rs 2,087 Cr (+32.9% reported, +34.7% LFL), EBITDA Rs 111 Cr at 5.3% margin, PAT Rs 61 Cr (+66%). Strategy: consolidate fragmented distribution and scale MedTech (IVD, cardio-ortho).
Entero Healthcare Solutions Q2 FY27 Results: Net Profit ₹60.7 Cr, Up 65.8% YoY
Entero Healthcare Solutions Ltd reported revenue from operations of ₹2,087 Cr (+32.9% YoY) and net profit of ₹60.7 Cr (+65.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹60.7 Cr · +65.8% YoY
Entero Healthcare Solutions Other Announcement
Entero Healthcare Solutions filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing reports promoter and public holdings, with no transaction or corporate event.
Entero Healthcare Solutions Board Meeting Date
Entero Healthcare Solutions scheduled a board meeting for November 04, 2026, to consider and approve unaudited financial results for the quarter ended September 30, 2026.
Entero Healthcare Solutions Other Announcement
Entero Healthcare Solutions Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b) for the period ending September 2026.
Other annual general meeting announcements
All →Meesho Annual General Meeting
Meesho seeks postal ballot approval, with voting closing 08-Dec-2026, to appoint Sudhir Sitapati as Independent Director. The resolution also covers ₹1 Crore annual remuneration.
Indrayani Biotech Annual General Meeting
Indrayani Biotech's 34th AGM is set for 30 November 2026, with book closure from 24 to 30 November. Remote e-voting runs 27 to 29 November 2026.
Kirloskar Ferrous Industries Annual General Meeting
Kirloskar Ferrous shareholders approved Ajay Shriram Patil's appointment as Director and Joint Managing Director via postal ballot. Both ordinary resolutions passed with over 98% votes in favour.
Gland Pharma Annual General Meeting
Gland Pharma's shareholders approved the appointment of Xingli Wang as Non-Executive Non-Independent Director via postal ballot. The ordinary resolution passed with 97.07% of votes in favour.
HDFC Bank Annual General Meeting
HDFC Bank's postal ballot passed the appointment of Anup Bagchi as Managing Director and CEO. Approval was deemed on 6 November 2026 with 98.646% votes in favour.
Britannia Industries Annual General Meeting
Britannia shareholders passed the special resolution appointing Sonny Iqbal as Non-Executive Independent Director via postal ballot. Approval was 99.7187% in favour of votes polled.